Skip to main content
Equibles

Parallel Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1690010 SAN FRANCISCO, CA
Back to AMGN Full portfolio

Position in AMGN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$4,033,654
+$450,766 QoQ
Shares Held
11,139
+9.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#941
of 3,155 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. AMGN ranks #6 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 31,933 $38,301,401
2 ABBV
AbbVie Inc.
 100,846 $25,376,887
3 JNJ
Johnson & Johnson
 83,035 $21,088,398
4 GILD
Gilead Sciences, Inc.
 76,862 $9,710,745
5 MRK
Merck & Co., Inc.
 66,774 $8,580,459
6 AMGN
Amgen Inc
This page 		11,139 $4,033,654
7 NVO
Novo Nordisk A S
 56,877 $2,726,683
8 NVS
Novartis AG
 15,640 $2,451,100

All Filings in AMGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,033,654 11,139
2026-03-31 $3,582,888 10,183
2025-12-31 $3,301,575 10,087
2025-09-30 $2,936,855 10,407
2025-06-30 $2,735,420 9,797
2025-03-31 $3,093,379 9,929
2024-12-31 $2,445,845 9,384
2024-09-30 $3,246,265 10,075
2024-06-30 $2,877,664 9,210
2024-03-31 $2,598,684 9,140
2023-12-31 $2,578,931 8,954
2023-09-30 $2,526,344 9,400
2023-06-30 $1,852,756 8,345
2023-03-31 $2,438,048 10,085
2022-12-31 $2,434,410 9,269
2022-09-30 $2,090,359 9,274
2022-06-30 $2,156,854 8,865
2022-03-31 $2,099,239 8,681
2021-12-31 $1,728,894 7,685
2021-09-30 $1,493,653 7,024
2021-06-30 $1,784,250 7,320
2021-03-31 $1,839,949 7,395
2020-12-31 $1,588,977 6,911
2020-09-30 $2,278,036 8,963
2020-06-30 $1,942,307 8,235
2020-03-31 $1,602,783 7,906